Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Regulatory News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,026.00
Bid: 11,054.00
Ask: 12,100.00
Change: 0.00 (0.00%)
Spread: 1,046.00 (9.463%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,026.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Date   Source Headline
2nd Jun 20167:00 amRNSAZ LICENSES ZURAMPIC TO GRÜNENTHAL GMBH
1st Jun 201612:00 pmRNSBlock listing Interim Review
1st Jun 201611:30 amRNSTotal Voting Rights
27th May 201612:36 pmRNSPOSITIVE CHMP OPINION IN EU FOR SAXA/DAPA
27th May 20167:03 amRNSPositive results from AstraZeneca Faslodex trial
27th May 20167:00 amRNSAstraZeneca receives CRL from US FDA for ZS-9
23rd May 20164:00 pmRNSDirector/PDMR Shareholding
18th May 20167:00 amRNSTOP-LINE RESULTS FROM LYNPARZA GOLD TRIAL
17th May 20167:00 amRNSPOSITIVE BENRALIZUMAB RESULTS IN SEVERE ASTHMA
12th May 20167:00 amRNSSELUMETINIB GRANTED ORPHAN DRUG DESIGNATION IN US
11th May 20165:30 pmRNSPublication of Final Terms
9th May 20165:35 pmRNSLaunch and pricing of EUR2.2bn bond issues
5th May 20163:00 pmRNSPublication of a Prospectus
3rd May 20161:30 pmRNSTotal Voting Rights
3rd May 20167:01 amRNSAstraZeneca completes divestment of Imdur
3rd May 20167:00 amRNSAZ COMPLETES ACQUISITION OF TAKEDA RESPIRATORY
29th Apr 20165:30 pmRNSResult of AGM
29th Apr 201612:46 pmRNSPOSITIVE CHMP OPINION FOR CAZ AVI
29th Apr 20167:00 amRNSAZN: 1st Quarter Results
28th Apr 20169:00 amRNSNotice of Results
26th Apr 20169:29 amRNSAZ enters US licensing agreement with Ironwood
26th Apr 20167:01 amRNSBEVESPI AEROSPHERE APPROVED BY US FDA FOR COPD
8th Apr 20167:00 amRNSAZ TO CONTINUE PIVOTAL ALZHEIMER'S CLINICAL TRIAL
1st Apr 201611:30 amRNSTotal Voting Rights
29th Mar 20167:00 amRNSTAGRISSO APPROVED IN JAPAN FOR CANCER PATIENTS
24th Mar 20163:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20167:00 amRNSAZ reports results from Brilinta stroke trial
18th Mar 201610:30 amRNSNotice of AGM
8th Mar 20166:29 pmRNSFiling of Form 20-F with SEC
8th Mar 201612:00 pmRNSAnnual Financial Report
1st Mar 20162:30 pmRNSTotal Voting Rights
29th Feb 20161:45 pmRNSAZ REPORTS TOP-LINE RESULT OF TREMELIMUMAB TRIAL
29th Feb 20167:59 amRNSAZ enters licensing agreement with CMS for Plendil
26th Feb 201612:00 pmRNSDirector/PDMR Shareholding
25th Feb 20168:57 amRNSACALABRUTINIB ORPHAN DRUG DESIGNATION RECOMMENDED
19th Feb 20167:05 amRNSBRILIQUE APPROVED IN EU FOR HEART ATTACK PATIENTS
19th Feb 20167:00 amRNSZURAMPIC APPROVED IN EU FOR GOUT PATIENTS
17th Feb 20167:00 amRNSDurvalumab granted BTD by FDA for cancer patients
16th Feb 20168:01 amRNSNEW EXTERNAL BOARD APPOINTMENT
4th Feb 20167:00 amRNSAstraZeneca Full-Year and Q4 2015 Results
3rd Feb 20169:00 amRNSNotice of Results
3rd Feb 20167:00 amRNSTAGRISSO approved in EU for cancer patients
2nd Feb 20169:05 amRNSAZ Completes transaction with Acerta Pharma
1st Feb 20162:32 pmRNSTotal Voting Rights
28th Jan 20167:00 amRNSLynparza Granted BTD in US for Prostate Cancer
4th Jan 20162:00 pmRNSDirector/PDMR Shareholding
4th Jan 20162:00 pmRNSDirector/PDMR Shareholding
4th Jan 20161:30 pmRNSTotal Voting Rights
23rd Dec 20154:30 pmRNSResult of External Audit Tender
23rd Dec 20157:00 amRNSLESINURAD APPROVED BY US FDA FOR GOUT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.